Association Between Anti-diabetic Agents and Clinical Outcomes of COVID-19 in Patients with Diabetes: A Systematic Review and Meta-Analysis

{ 'indexed': {'date-parts': [[2024, 5, 11]], 'date-time': '2024-05-11T09:10:52Z', 'timestamp': 1715418652701}, 'reference-count': 73, 'publisher': 'Elsevier BV', 'issue': '2', 'license': [ { 'start': { 'date-parts': [[2022, 2, 1]], 'date-time': '2022-02-01T00:00:00Z', 'timestamp': 1643673600000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'content-domain': { 'domain': [ 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.fr', 'clinicalkey.com.au', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2022, 2]]}, 'DOI': '10.1016/j.arcmed.2021.08.002', 'type': 'journal-article', 'created': {'date-parts': [[2021, 8, 9]], 'date-time': '2021-08-09T03:30:15Z', 'timestamp': 1628479815000}, 'page': '186-195', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 31, 'title': 'Association Between Anti-diabetic Agents and Clinical Outcomes of COVID-19 in Patients with ' 'Diabetes: A Systematic Review and Meta-Analysis', 'prefix': '10.1016', 'volume': '53', 'author': [ {'given': 'Tiantian', 'family': 'Han', 'sequence': 'first', 'affiliation': []}, {'given': 'Shaodi', 'family': 'Ma', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0003-3812-3164', 'authenticated-orcid': False, 'given': 'Chenyu', 'family': 'Sun', 'sequence': 'additional', 'affiliation': []}, {'given': 'Huimei', 'family': 'Zhang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Guangbo', 'family': 'Qu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yue', 'family': 'Chen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ce', 'family': 'Cheng', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eric L.', 'family': 'Chen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mubashir', 'family': 'Ayaz Ahmed', 'sequence': 'additional', 'affiliation': []}, {'given': 'Keun Young', 'family': 'Kim', 'sequence': 'additional', 'affiliation': []}, {'given': 'Raveena', 'family': 'Manem', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mengshi', 'family': 'Chen', 'sequence': 'additional', 'affiliation': []}, {'given': 'Zhichun', 'family': 'Guo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hongru', 'family': 'Yang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yue', 'family': 'Yan', 'sequence': 'additional', 'affiliation': []}, {'given': 'Qin', 'family': 'Zhou', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.arcmed.2021.08.002_bib0001', 'doi-asserted-by': 'crossref', 'first-page': '436', 'DOI': '10.1016/j.jmii.2020.03.034', 'article-title': 'Treatment options for COVID-19: The reality and challenges', 'volume': '53', 'author': 'Jean', 'year': '2020', 'journal-title': 'J Microbiol Immunol Infect'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0002', 'doi-asserted-by': 'crossref', 'first-page': '250', 'DOI': '10.1002/jmv.26232', 'article-title': 'The cytokine storm and COVID-19', 'volume': '93', 'author': 'Hu', 'year': '2021', 'journal-title': 'J Med Virol'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0003', 'first-page': 'e35', 'article-title': 'Prevalence of Underlying Diseases in Hospitalized Patients with ' 'COVID-19: a Systematic Review and Meta-Analysis', 'volume': '8', 'author': 'Emami', 'year': '2020', 'journal-title': 'Arch Acad Emerg Med'}, { 'issue': '2', 'key': '10.1016/j.arcmed.2021.08.002_bib0004', 'doi-asserted-by': 'crossref', 'DOI': '10.1136/bmjopen-2020-045482', 'article-title': 'Cardiovascular risk factors and COVID-19 outcomes in hospitalised ' 'patients: a prospective cohort study', 'volume': '11', 'author': 'Collard', 'year': '2021', 'journal-title': 'BMJ open'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0005', 'first-page': '113', 'article-title': 'The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team ' '(Team TNCP). The Epidemiological Characteristics of an Outbreak of 2019 ' 'Novel Coronavirus Diseases (COVID-19)- China', 'volume': '2', 'year': '2020', 'journal-title': 'China CDC Wkly 2020'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0006', 'article-title': 'Division of Viral Diseases (DOVD)', 'year': '2020', 'journal-title': 'Evidence used to update the list of underlying medical conditions that ' "increase a person's risk of severe illness from COVID-19"}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0007', 'doi-asserted-by': 'crossref', 'first-page': '395', 'DOI': '10.1016/j.dsx.2020.04.018', 'article-title': 'Diabetes mellitus is associated with increased mortality and severity ' 'of disease in COVID-19 pneumonia-A systematic review, meta-analysis, ' 'and meta-regression', 'volume': '14', 'author': 'Huang', 'year': '2020', 'journal-title': 'Diabetes Metab Syndr'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0008', 'first-page': '292', 'article-title': 'Guidelines for the prevention and control of type 2 diabetes in China', 'volume': '38', 'year': '2018', 'journal-title': 'Chinese Journal of Practical Internal Medicine'}, { 'issue': 'S1', 'key': '10.1016/j.arcmed.2021.08.002_bib0009', 'first-page': 'S111', 'article-title': 'Pharmacologic Approaches to Glycemic Treatment: Standards of Medical ' 'Care in Diabetes-2021', 'volume': '44', 'author': '9', 'year': '2021', 'journal-title': 'Diabetes Care'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0010', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.diabres.2020.108282', 'article-title': 'A proposed mechanism for the possible therapeutic potential of ' 'Metformin in COVID-19', 'volume': '167', 'author': 'Esam', 'year': '2020', 'journal-title': 'Diabetes Res Clin Pract'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0011', 'doi-asserted-by': 'crossref', 'first-page': '537', 'DOI': '10.1016/j.cmet.2020.08.013', 'article-title': 'Metformin Is Associated with Higher Incidence of Acidosis, but Not ' 'Mortality, in Individuals with COVID-19 and Pre-existing Type 2 ' 'Diabetes', 'volume': '32', 'author': 'Cheng', 'year': '2020', 'journal-title': 'Cell Metab'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0012', 'doi-asserted-by': 'crossref', 'first-page': '69', 'DOI': '10.4269/ajtmh.20-0375', 'article-title': 'Metformin Treatment Was Associated with Decreased Mortality in COVID-19 ' 'Patients with Diabetes in a Retrospective Analysis', 'volume': '103', 'author': 'Luo', 'year': '2020', 'journal-title': 'Am J Trop Med Hyg'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0013', 'doi-asserted-by': 'crossref', 'first-page': '1185', 'DOI': '10.3389/fphar.2020.01185', 'article-title': 'DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, ' 'Heart and Kidney Injury Caused by COVID-19-A Therapeutic Approach of ' 'Choice in Type 2 Diabetic Patients?', 'volume': '11', 'author': 'Smelcerovic', 'year': '2020', 'journal-title': 'Front Pharmacol'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0014', 'doi-asserted-by': 'crossref', 'first-page': '846', 'DOI': '10.1186/s13063-020-04619-1', 'volume': '21', 'author': 'Duvignaud', 'year': '2020', 'journal-title': 'Trials'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0015', 'doi-asserted-by': 'crossref', 'first-page': '263', 'DOI': '10.1111/dom.14203', 'article-title': 'Sodium-glucose co-transporter-2 inhibitors and susceptibility to ' 'COVID-19: A population-based retrospective cohort study', 'volume': '23', 'author': 'Sainsbury', 'year': '2021', 'journal-title': 'Diabetes Obes Metab'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0016', 'article-title': 'The Newcastle-Ottawa Scale (NOS) for assessing the quality of ' 'nonrandomised studies in meta-analyses', 'author': 'Wells', 'year': '2000', 'journal-title': 'Ottawa Hospital Research Institute'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0017', 'doi-asserted-by': 'crossref', 'first-page': 'd671', 'DOI': '10.1136/bmj.d671', 'article-title': 'Association of alcohol consumption with selected cardiovascular disease ' 'outcomes: a systematic review and meta-analysis', 'volume': '342', 'author': 'Ronksley', 'year': '2011', 'journal-title': 'BMJ'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0018', 'first-page': '59', 'article-title': 'Odds Ratio, Hazard Ratio and Relative Risk', 'volume': '13', 'author': 'Stare', 'year': '2016', 'journal-title': 'Metodoloski Zvezki'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0019', 'doi-asserted-by': 'crossref', 'first-page': '4273', 'DOI': '10.1002/jmv.26873', 'article-title': 'Outpatient metformin use is associated with reduced severity of ' 'COVID-19 disease in adults with overweight or obesity', 'volume': '93', 'author': 'Bramante', 'year': '2021', 'journal-title': 'J Med Virol'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0020', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.lfs.2021.119371', 'article-title': 'Effects of metformin, insulin on COVID-19 patients with pre-existed ' 'type 2 diabetes: A multicentral retrospective study', 'volume': '275', 'author': 'Cheng', 'year': '2021', 'journal-title': 'Life Sci'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0021', 'doi-asserted-by': 'crossref', 'first-page': '513', 'DOI': '10.1016/j.dsx.2021.02.022', 'article-title': 'Metformin is associated with lower hospitalizations, mortality and ' 'severe coronavirus infection among elderly medicare minority patients ' 'in 8 states in USA', 'volume': '15', 'author': 'Ghany', 'year': '2021', 'journal-title': 'Diabetes Metab Syndr'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0022', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.diabres.2020.108619', 'article-title': 'Association of metformin with mortality or ARDS in patients with ' 'COVID-19 and type 2 diabetes: A retrospective cohort study', 'volume': '173', 'author': 'Jiang', 'year': '2021', 'journal-title': 'Diabetes Res Clin Pract'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0023', 'doi-asserted-by': 'crossref', 'first-page': '293', 'DOI': '10.1016/S2213-8587(21)00050-4', 'article-title': 'Prescription of glucose-lowering therapies and risk of COVID-19 ' 'mortality in people with type 2 diabetes: a nationwide observational ' 'study in England', 'volume': '9', 'author': 'Khunti', 'year': '2021', 'journal-title': 'Lancet Diabetes Endocrinol'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0024', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.diabet.2020.101216', 'article-title': 'Metformin use is associated with a reduced risk of mortality in ' 'patients with diabetes hospitalised for COVID-19', 'volume': '47', 'author': 'Lalau', 'year': '2021', 'journal-title': 'Diabetes Metab'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0025', 'doi-asserted-by': 'crossref', 'first-page': '193', 'DOI': '10.1016/j.jamda.2020.10.031', 'article-title': 'Metformin is Associated with Decreased 30-Day Mortality Among Nursing ' 'Home Residents Infected with SARS-CoV2', 'volume': '22', 'author': 'Lally', 'year': '2021', 'journal-title': 'J Am Med Dir Assoc'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0026', 'doi-asserted-by': 'crossref', 'first-page': '33', 'DOI': '10.1016/j.dsx.2020.12.014', 'article-title': 'Predictors of adverse in-hospital outcome and recovery in patients with ' 'diabetes mellitus and COVID-19 pneumonia in Iraq', 'volume': '15', 'author': 'Nafakhi', 'year': '2021', 'journal-title': 'Diabetes Metab Syndr'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0027', 'doi-asserted-by': 'crossref', 'first-page': '771', 'DOI': '10.1007/s00592-020-01666-7', 'article-title': 'Metformin use and risk of COVID-19 among patients with type II diabetes ' 'mellitus: an NHIS-COVID-19 database cohort study', 'volume': '58', 'author': 'Oh', 'year': '2021', 'journal-title': 'Acta Diabetol'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0028', 'doi-asserted-by': 'crossref', 'first-page': '359', 'DOI': '10.1186/s12916-020-01832-2', 'article-title': 'Mortality and other adverse outcomes in patients with type 2 diabetes ' 'mellitus admitted for COVID-19 in association with glucose-lowering ' 'drugs: a nationwide cohort study', 'volume': '18', 'author': 'Pérez-Belmonte', 'year': '2020', 'journal-title': 'BMC Med'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0029', 'doi-asserted-by': 'crossref', 'first-page': '396', 'DOI': '10.1016/j.numecd.2020.09.028', 'article-title': 'Are diabetes and its medications risk factors for the development of ' 'COVID-19? Data from a population-based study in Sicily', 'volume': '31', 'author': 'Silverii', 'year': '2021', 'journal-title': 'Nutr Metab Cardiovasc Dis'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0030', 'article-title': 'Associations of comorbidities and medications with COVID-19 outcome: A ' 'retrospective analysis of real-world evidence data', 'author': 'Abu-Jamous', 'year': '20200820', 'journal-title': 'medRxiv'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0031', 'doi-asserted-by': 'crossref', 'first-page': 'e34', 'DOI': '10.1016/S2666-7568(20)30033-7', 'article-title': 'Metformin and risk of mortality in patients hospitalised with COVID-19: ' 'a retrospective cohort analysis', 'volume': '2', 'author': 'Bramante', 'year': '2021', 'journal-title': 'Lancet Healthy Longev'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0032', 'doi-asserted-by': 'crossref', 'first-page': '1399', 'DOI': '10.2337/dc20-0660', 'article-title': 'Clinical Characteristics and Outcomes of Patients With Diabetes and ' 'COVID-19 in Association With Glucose-Lowering Medication', 'volume': '43', 'author': 'Chen', 'year': '2020', 'journal-title': 'Diabetes Care'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0033', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fendo.2020.600439', 'article-title': 'Metformin Use Is Associated With Reduced Mortality in a Diverse ' 'Population With COVID-19 and Diabetes', 'volume': '11', 'author': 'Crouse', 'year': '2021', 'journal-title': 'Front Endocrinol (Lausanne)'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0034', 'article-title': 'Is there an association between metformin use and clinical outcomes in ' 'diabetes patients with COVID-19?', 'volume': '101208', 'author': 'Do', 'year': '2020', 'journal-title': 'Diabetes Metab'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0035', 'doi-asserted-by': 'crossref', 'first-page': '1055', 'DOI': '10.1111/cts.12897', 'article-title': 'Risk of Metformin in Patients With Type 2 Diabetes With COVID-19: A ' 'Preliminary Retrospective Report', 'volume': '13', 'author': 'Gao', 'year': '2020', 'journal-title': 'Clin Transl Sci'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0036', 'doi-asserted-by': 'crossref', 'first-page': '602', 'DOI': '10.4093/dmj.2020.0146', 'article-title': 'The Clinical Characteristics and Outcomes of Patients with ' 'Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in ' 'Daegu, South Korea', 'volume': '44', 'author': 'Kim', 'year': '2020', 'journal-title': 'Diabetes Metab J'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0037', 'doi-asserted-by': 'crossref', 'first-page': '35', 'DOI': '10.14341/probl12458', 'article-title': 'Diabetes and COVID-19: analysis of the clinical outcomes according to ' 'the data of the Russian diabetes registry', 'volume': '66', 'author': 'Shestakova', 'year': '2020', 'journal-title': 'Probl Endokrinol (Mosk)'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0038', 'doi-asserted-by': 'crossref', 'first-page': '1946', 'DOI': '10.1111/dom.14097', 'article-title': 'Exposure to dipeptidyl-peptidase-4 inhibitors and COVID-19 among people ' 'with type 2 diabetes: A case-control study', 'volume': '22', 'author': 'Fadini', 'year': '2020', 'journal-title': 'Diabetes Obes Metab'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0039', 'doi-asserted-by': 'crossref', 'first-page': '251', 'DOI': '10.4093/dmj.2020.0206', 'article-title': 'Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of ' 'Patients with Diabetes and COVID-19', 'volume': '45', 'author': 'Rhee', 'year': '2021', 'journal-title': 'Diabetes Metab J'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0040', 'doi-asserted-by': 'crossref', 'first-page': '2999', 'DOI': '10.2337/dc20-1521', 'article-title': 'Sitagliptin Treatment at the Time of Hospitalization Was Associated ' 'With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A ' 'Multicenter, Case-Control, Retrospective, Observational Study', 'volume': '43', 'author': 'Solerte', 'year': '2020', 'journal-title': 'Diabetes Care'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0041', 'doi-asserted-by': 'crossref', 'first-page': 'e48', 'DOI': '10.1093/ehjcvp/pvaa098', 'article-title': 'The association of hypertension and diabetes pharmacotherapy with ' 'COVID-19 severity and immune signatures: an observational study', 'volume': '7', 'author': 'Dalan', 'year': '2021', 'journal-title': 'Eur Heart J Cardiovasc Pharmacother'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0042', 'doi-asserted-by': 'crossref', 'first-page': '1397', 'DOI': '10.1111/dom.14329', 'article-title': 'Comparable COVID-19 outcomes with current use of GLP-1 receptor ' 'agonists, DPP-4 inhibitors, or SGLT-2 inhibitors among patients with ' 'diabetes who tested positive for SARS-CoV-2', 'volume': '23', 'author': 'Israelsen', 'year': '2021', 'journal-title': 'Diabetes Obes Metab'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0043', 'doi-asserted-by': 'crossref', 'first-page': 'e64', 'DOI': '10.2337/dc20-1824', 'article-title': 'Association Between DPP-4 Inhibitors and COVID-19-Related Outcomes ' 'Among Patients With Type 2 Diabetes', 'volume': '44', 'author': 'Noh', 'year': '2021', 'journal-title': 'Diabetes Care'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0044', 'doi-asserted-by': 'crossref', 'first-page': '1162', 'DOI': '10.1111/dom.14324', 'article-title': 'Use of dipeptidyl peptidase-4 inhibitors and prognosis of COVID-19 in ' 'hospitalized patients with type 2 diabetes: A propensity score analysis ' 'from the CORONADO study', 'volume': '23', 'author': 'Roussel', 'year': '2021', 'journal-title': 'Diabetes Obes Metab'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0045', 'doi-asserted-by': 'crossref', 'first-page': '5576', 'DOI': '10.12998/wjcc.v8.i22.5576', 'article-title': 'No significant association between dipeptidyl peptidase-4 inhibitors ' 'and adverse outcomes of COVID-19', 'volume': '8', 'author': 'Zhou', 'year': '2020', 'journal-title': 'World J Clin Cases'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0046', 'doi-asserted-by': 'crossref', 'first-page': '778', 'DOI': '10.1007/s00125-020-05351-w', 'article-title': 'Predictors of hospital discharge and mortality in patients with ' 'diabetes and COVID-19: updated results from the nationwide CORONADO ' 'study', 'volume': '64', 'author': 'Wargny', 'year': '2021', 'journal-title': 'Diabetologia'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0047', 'doi-asserted-by': 'crossref', 'first-page': '1953', 'DOI': '10.1007/s00125-020-05207-3', 'article-title': 'Correction to: Phenotypic characteristics and prognosis of inpatients ' 'with COVID-19 and diabetes: the CORONADO study', 'volume': '63', 'author': 'Cariou', 'year': '2020', 'journal-title': 'Diabetologia'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0048', 'article-title': 'Metformin use is associated with reduced mortality rate from ' 'coronavirus disease 2019 (COVID-19) infection', 'volume': '19', 'author': 'Hariyanto', 'year': '2020', 'journal-title': 'Obes Med'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0049', 'doi-asserted-by': 'crossref', 'first-page': '2177', 'DOI': '10.1016/j.dsx.2020.11.006', 'article-title': 'The Effect of Metformin Consumption on Mortality in Hospitalized ' 'COVID-19 patients: a systematic review and meta-analysis', 'volume': '14', 'author': 'Lukito', 'year': '2020', 'journal-title': 'Diabetes Metab Syndr'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0050', 'doi-asserted-by': 'crossref', 'DOI': '10.3389/fendo.2021.645194', 'article-title': 'The Efficacy and Potential Mechanisms of Metformin in the Treatment of ' 'COVID-19 in the Diabetics: A Systematic Review', 'volume': '12', 'author': 'Zangiabadian', 'year': '2021', 'journal-title': 'Front Endocrinol (Lausanne)'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0051', 'doi-asserted-by': 'crossref', 'first-page': '695', 'DOI': '10.1002/jmv.26498', 'article-title': 'Mortality risk with preadmission metformin use in patients with ' 'COVID-19 and diabetes: A meta-analysis', 'volume': '93', 'author': 'Kow', 'year': '2021', 'journal-title': 'J Med Virol'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0052', 'doi-asserted-by': 'crossref', 'first-page': '863', 'DOI': '10.1177/0885066618793385', 'article-title': 'Review of Biguanide (Metformin) Toxicity', 'volume': '34', 'author': 'Wang', 'year': '2019', 'journal-title': 'J Intensive Care Med'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0053', 'doi-asserted-by': 'crossref', 'first-page': '2056', 'DOI': '10.3389/fimmu.2020.02056', 'article-title': 'Immunomodulatory and Antiviral Activity of Metformin and Its Potential ' 'Implications in Treating Coronavirus Disease 2019 and Lung Injury', 'volume': '11', 'author': 'Chen', 'year': '2020', 'journal-title': 'Front Immunol'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0054', 'first-page': '1131', 'article-title': 'Metformin: one of the possible options to reduce the mortality of ' 'severe coronavirus disease 2019?', 'volume': '32', 'author': 'Pan', 'year': '2020', 'journal-title': 'Zhonghua wei zhong bing ji jiu yi xue'}, { 'issue': '9', 'key': '10.1016/j.arcmed.2021.08.002_bib0055', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.isci.2020.101425', 'article-title': 'ACE2, Metformin, and COVID-19', 'volume': '23', 'author': 'Malhotra', 'year': '2020', 'journal-title': 'iScience'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0056', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.diabres.2020.108183', 'article-title': 'Metformin in COVID-19: A possible role beyond diabetes', 'volume': '164', 'author': 'Sharma', 'year': '2020', 'journal-title': 'Diabetes Res Clin Pract'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0057', 'doi-asserted-by': 'crossref', 'first-page': '1379', 'DOI': '10.1007/s40618-021-01515-6', 'article-title': 'Disentangling conflicting evidence on DPP-4 inhibitors and outcomes of ' 'COVID-19: narrative review and meta-analysis', 'volume': '44', 'author': 'Bonora', 'year': '2021', 'journal-title': 'J Endocrinol Invest'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0058', 'doi-asserted-by': 'crossref', 'first-page': '777', 'DOI': '10.1016/j.dsx.2021.03.027', 'article-title': 'Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus ' 'disease 2019 (COVID-19)-A systematic review, meta-analysis, and ' 'meta-regression', 'volume': '15', 'author': 'Rakhmat', 'year': '2021', 'journal-title': 'Diabetes Metab Syndr'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0059', 'doi-asserted-by': 'crossref', 'DOI': '10.1177/2042018821996482', 'article-title': 'Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients ' 'with diabetes mellitus: an updated systematic review and meta-analysis', 'volume': '12', 'author': 'Pal', 'year': '2021', 'journal-title': 'Ther Adv Endocrinol Metab'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0060', 'doi-asserted-by': 'crossref', 'first-page': '1185', 'DOI': '10.1002/cpt.2047', 'article-title': 'Role of Drugs Used for Chronic Disease Management on Susceptibility and ' 'Severity of COVID-19: A Large Case-Control Study', 'volume': '108', 'author': 'Yan', 'year': '2020', 'journal-title': 'Clin Pharmacol Ther'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0061', 'doi-asserted-by': 'crossref', 'first-page': '265', 'DOI': '10.1016/j.diabet.2020.05.008', 'article-title': 'Prognostic factors in patients with diabetes hospitalized for COVID-19: ' 'Findings from the CORONADO study and other recent reports', 'volume': '46', 'author': 'Scheen', 'year': '2020', 'journal-title': 'Diabetes Metab'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0062', 'doi-asserted-by': 'crossref', 'first-page': '175', 'DOI': '10.2478/acph-2021-0013', 'article-title': 'Sitagliptin: a potential drug for the treatment of COVID-19?', 'volume': '71', 'author': 'Bardaweel', 'year': '2021', 'journal-title': 'Acta Pharm'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0063', 'doi-asserted-by': 'crossref', 'first-page': '2335', 'DOI': '10.1038/s41366-020-00689-y', 'article-title': 'Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in ' 'human subjects hospitalized for severe COVID-19 infections', 'volume': '44', 'author': 'Schlicht', 'year': '2020', 'journal-title': 'Int J Obes (Lond)'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0064', 'doi-asserted-by': 'crossref', 'first-page': '245', 'DOI': '10.1007/s00592-020-01629-y', 'article-title': 'Use of DPP-4 inhibitors in patients with COVID-19', 'volume': '58', 'author': 'Kow', 'year': '2021', 'journal-title': 'Acta Diabetol'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0065', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.mehy.2020.110111', 'article-title': 'Inflammation: A bridge between diabetes and COVID-19, and possible ' 'management with sitagliptin', 'volume': '143', 'author': 'Mozafari', 'year': '2020', 'journal-title': 'Med Hypotheses'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0066', 'doi-asserted-by': 'crossref', 'first-page': '10', 'DOI': '10.1016/j.bbrc.2020.05.206', 'article-title': 'SARS-CoV-2 E protein is a potential ion channel that can be inhibited ' 'by Gliclazide and Memantine', 'volume': '530', 'author': 'Singh Tomar', 'year': '2020', 'journal-title': 'Biochem Biophys Res Commun'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0067', 'doi-asserted-by': 'crossref', 'first-page': '405', 'DOI': '10.1016/j.dsx.2020.04.024', 'article-title': 'Can dapagliflozin have a protective effect against COVID-19 infection? ' 'A hypothesis', 'volume': '14', 'author': 'Cure', 'year': '2020', 'journal-title': 'Diabetes Metab Syndr'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0068', 'doi-asserted-by': 'crossref', 'first-page': '115', 'DOI': '10.1186/s12933-020-01090-9', 'article-title': 'Treating type 2 diabetes in COVID-19 patients: the potential benefits ' 'of injective therapies', 'volume': '19', 'author': 'Longo', 'year': '2020', 'journal-title': 'Cardiovasc Diabetol'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0069', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1007/s13300-020-00830-0', 'article-title': 'COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the ' "New Philosopher's Stone?", 'volume': '11', 'author': 'Penlioglou', 'year': '2020', 'journal-title': 'Diabetes Ther'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0070', 'doi-asserted-by': 'crossref', 'first-page': '713', 'DOI': '10.1016/j.dsx.2020.05.007', 'article-title': 'Role of oxidized LDL-induced “trained macrophages” in the pathogenesis ' 'of COVID-19 and benefits of pioglitazone: A hypothesis', 'volume': '14', 'author': 'Erol', 'year': '2020', 'journal-title': 'Diabetes Metab Syndr'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0071', 'doi-asserted-by': 'crossref', 'first-page': '1068', 'DOI': '10.1016/j.cmet.2020.04.021', 'article-title': 'Association of Blood Glucose Control and Outcomes in Patients with ' 'COVID-19 and Pre-existing Type 2 Diabetes', 'volume': '31', 'author': 'Zhu', 'year': '2020', 'journal-title': 'Cell Metab'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0072', 'doi-asserted-by': 'crossref', 'first-page': '366', 'DOI': '10.1161/HYPERTENSIONAHA.120.15324', 'article-title': 'Age and Multimorbidity Predict Death Among COVID-19 Patients', 'volume': '76', 'author': 'Iaccarino', 'year': '2020', 'journal-title': 'Hypertension'}, { 'key': '10.1016/j.arcmed.2021.08.002_bib0073', 'doi-asserted-by': 'crossref', 'first-page': '1255', 'DOI': '10.1210/clinem/dgab067', 'article-title': 'Association of Metformin with Susceptibility to COVID-19 in People with ' 'Type 2 Diabetes', 'volume': '106', 'author': 'Wang', 'year': '2021', 'journal-title': 'J Clin Endocrinol Metab'}], 'container-title': 'Archives of Medical Research', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0188440921001673?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0188440921001673?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2022, 3, 9]], 'date-time': '2022-03-09T03:09:04Z', 'timestamp': 1646795344000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0188440921001673'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 2]]}, 'references-count': 73, 'journal-issue': {'issue': '2', 'published-print': {'date-parts': [[2022, 2]]}}, 'alternative-id': ['S0188440921001673'], 'URL': 'http://dx.doi.org/10.1016/j.arcmed.2021.08.002', 'relation': { 'has-preprint': [ { 'id-type': 'doi', 'id': '10.1101/2021.01.26.21250506', 'asserted-by': 'object'}]}, 'ISSN': ['0188-4409'], 'subject': [], 'container-title-short': 'Archives of Medical Research', 'published': {'date-parts': [[2022, 2]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Association Between Anti-diabetic Agents and Clinical Outcomes of COVID-19 in ' 'Patients with Diabetes: A Systematic Review and Meta-Analysis', 'name': 'articletitle', 'label': 'Article Title'}, {'value': 'Archives of Medical Research', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.arcmed.2021.08.002', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2021 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. ' 'All rights reserved.', 'name': 'copyright', 'label': 'Copyright'}]}